QuantiPath, a leader in rapid pathogen detection and food safety diagnostics, today announced the appointment of Roger ...

We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Bio-Rad Laboratories, Inc. is among the ...

Rad, explores how droplet digital PCR (ddPCR) overcomes limitations of traditional PCR, reshaping how scientists approach ...

Life science company Bio-Rad Laboratories has extended its range of recombinant monoclonal anti -idiotypic antibodies. The ...

Bio-Rad Laboratories stock draws attention after trend movement. Explore drivers, sector position, and healthcare technology ...

First-year students enrolled in principles of biology at Commonwealth University-Lock Haven recently participated in a ...

Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli's next phase of growth ...

This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...

According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its ...

Bio-Rad Laboratories has broadened its portfolio of recombinant monoclonal antibodies used in bioanalysis and drug monitoring ...

Fintel reports that on April 7, 2026, Citigroup downgraded their outlook for Bio-Rad Laboratories (NYSE:BIO.B) from Buy to Neutral. Analyst Price Forecast Suggests ∞% Upside As of February 25, 2026, ...